Skip to main content
SpringerLink
Log in

Mechanisms of endothelial cell injury in vasculitis

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Summary

The aetiology of the primary systemic vasculitides remains obscure. Recent years have seen significant advances in our understanding of inflammation and in particular the role of and interaction between the vascular endothelium, mediators and immune effector cells. This has helped to further elucidate those specific processes relevant to vasculitis which result in endothelial cell damage. In Wegener's granulomatosis and microscopic polyarteritis the evidence favours an autoimmune inflammatory response characterised by specific mediators in which the endothelium is both target and active participant. Current treatment of these disorders with combinations of corticosteroids and cytotoxics is highly effective in inducing remission. However, long-term use of this therapy is potentially toxic and there remains also a significant risk of relapse [44]. It is hoped that increased understanding of the pathogenesis of systemic vasculitis will enable more specific, less toxic and more effective therapies to be defined. Jayne et al. [52] have suggested a beneficial effect of intravenous pooled normal human immunoglobulin (IVIG) in patients with ANCA-positive vasculitis. In vitro studies have shown that IVIG contains antiidiotypic antibodies to ANCA and AECA, capable of inhibiting the binding of these autoantibodies to their autoantigens [76, 80, 87]. In vivo, IVIG may also provide the immunoregulatory elements needed for the idiotype network and control of the autoimmune repertoire. Mathieson et al. [68] successfully used monoclonal antibodies to T cells (Campath-H directed against CDw52) in a patient with ANCA-negative dermal lymphocytic vasculitis. Monoclonal antibodies to CAMs have been used in human renal transplant rejection [63] and reduced the inflammation and proteinuria in animal models of anti-glomerular basement membrane disease [60]. In vasculitis, the therapeutic use of specific anti-CAM antibodies may result from further definition of the role of CAMs. Increased understanding of the pathogenesis of systemic vasculitis is likely to provide the basis for the use of more specific immunotherapies in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adu D, Howie AJ, Scott DGI, Bacon PA, McGonigle RJS, Michael J (1987) Polyarteritis and the kidney. Q J Med 62: 221

    Google Scholar 

  2. Adu D, Luqmani RA, Bacon RA (1993) Polyarteritis, Wegener's granulomatosis and Churg Strauss syndrome. In: Maddison PJ, Isenberg DA, Woo P, Glass DN (eds) Oxford textbook of rheumatology, vol 2. Oxford Medical Publications, Oxford, pp 846–859

    Google Scholar 

  3. Antonovych TT, Sabnis SG, Tuur SM, Sesterhenn IA, Balow JE (1989) Morphologic differences between polyarteritis and Wegener's granulomatosis using light, electron and immunohistochemical techniques. Modern Pathol 2: 349

    Google Scholar 

  4. Baltaro FJ, Hoffman GS, Sechler JMG, Suffredini AF, Shelhamer JH, Fauci AS, Fleisher TA (1991) Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. AM Rev Respir Dis 143: 275

    Google Scholar 

  5. Barrett TM, Thomason P, Taylor CM, Pall AA, Adu D (1993) Environmental trigger for antineutrophil cytoplasmic antibodies. Lancet 342: 369

    Google Scholar 

  6. Barth J, Petermann W, Zemke F, Kreipe H, Gross WL (1991) Bronchoalveolar lavage in Wegener's granulomatosis. Pneumologie 45: 570

    Google Scholar 

  7. Braquet P, Rola-Pleszozynski M (1987) Platelet-activating factor and cellular immune responses. Immunol Today 8: 345

    Google Scholar 

  8. Braverman IM, Yen A (1975) Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angiitis. J Invest Dermatol 64: 105

    CAS  PubMed  Google Scholar 

  9. Briscoe DM, Cotran RS (1993) Role of leucocyte-endothelial cell adhesion molecules in renal inflammation: in vitro and in vivo studies. Kidney Int 44 [Suppl 42]: S27

    Google Scholar 

  10. Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CGM (1991) Immunohistopathology of renal biopsies in Wegener's granulomatosis (WG): clues to its pathogenesis? Kidney Int 39: 1055

    Google Scholar 

  11. Brouwer E, Cohen Tervaert JW, Horst G, Huidema MG, van der Giessen M, Limburg PC, Kallenberg CGM (1991) Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 83: 379

    Google Scholar 

  12. Brouwer E, Huitema MG, Klok PA, de Weerd H, Cohen Tervaert JW, Weening JJ, Kallenberg CGM (1993) Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med 177: 905

    Google Scholar 

  13. Calafat J, Goldschmeding R, Ringeling PL, Janssen H, van der Schoot DE (1990) In situ localization by double-labeling immunoelectron microscopy of antineutrophil cytoplasmic autoantibodies in neutrophils and monocytes. Blood 75: 242

    Google Scholar 

  14. Carrington CB, Liebow AA (1966) Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med 41: 497

    Google Scholar 

  15. Carvalho D, Adamson P, Savage COS, Pearson JD (1994) Antiendothelial cell autoantibodies induce cytokine release and leukocyte adhesion. Nephrol Dial Transplant (in press)

  16. Charles LA, Caldas MLR, Falk RJ, Terrel RS, Jennette JC (1991) Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 50: 539

    Google Scholar 

  17. Charles LA, Falk RJ, Jennette JC (1992) Reactivity of antineutrophil cytoplasmic antibodies with mononuclear phagocytes. J Leukoc Biol 51: 65

    Google Scholar 

  18. Cochrane CG, Koffler D (1973) Immune complex disease in experimental animals and man. Adv Immunol 16: 185

    Google Scholar 

  19. Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, Meijer S, van der Giessen M, The TH, van der Hem GK, Kallenberg CGM (1989) Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149: 2461

    Google Scholar 

  20. Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CGM (1990) Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336: 709

    Google Scholar 

  21. Csernok E, Ludemann J, Gross WL, Bainton DF (1990) Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am J Pathol 137: 1113

    Google Scholar 

  22. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL (1994) Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95: 244

    Google Scholar 

  23. D'Agati V, Chandler P, Nash ME, Mancilla-Jimenez RM (1986) Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vasculature and glomerular lesions. Am J Kidney Dis 7: 95

    Google Scholar 

  24. Davies DJ, Moran JE, Niall JF, Ryan GB (1982) Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J 285: 606

    Google Scholar 

  25. Deguchi Y, Shibata N, Kishimoto S (1990) Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin Exp Immunol 81: 311

    Google Scholar 

  26. Del Papa N, Meroni PL, Barcellini W, Sinico A, Radice A, Tincani A, D'Cruz D, Nicoletti F, Borghi MO, Khamashta MA, Hughes GRV, Balestrieri G (1992) Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol 63: 267

    Google Scholar 

  27. DeRemee RA, McDonald TJ, Weiland LH (1985) Wegener's granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc 60: 27

    Google Scholar 

  28. Donald KJ, Edwards RL, McEvoy JDS (1976) An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis. Pathology 8: 161

    Google Scholar 

  29. Egbring R, Seitz R, Andrassy K (1990) Activation of blood coagulation and endothelial dysfunction in patients with Wegener's granulomatosis and related disorders. APMIS 98 [Suppl 19]: 42

    Google Scholar 

  30. Egner W, Chapel HM (1990) Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitis. Clin Exp Immunol 82: 244

    Google Scholar 

  31. Elkon KB, Sutherland DC, Rees AJ, Hughes GRV, Batchelor JR (1983) HLA frequencies in systemic vasculitis. Increase in HLA-DR2 in Wegener's granulomatosis. Arthritis Rheum 26: 102

    Google Scholar 

  32. Ewert B, Becker M, Falk RJ, Jennette JC (1992) Anti-myeloperoxidase antibodies stimulate neutrophils to adhere to human umbilical vein endothelium. Kidney Int 41: 375

    Google Scholar 

  33. Ewert BH, Jennette JC, Falk RJ (1992) Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 41: 375

    Google Scholar 

  34. Ewert BH, Terrell RS, Wright C, Jennette JC, Falk RJ (1992) Anti-myeloperoxidase antibodies (αMPO) activate neutrophils using a phospholipase D-containing signal transduction pathway. J Am Soc Nephrol 3: 585

    Google Scholar 

  35. Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis. N Engl J Med 318: 1651

    Google Scholar 

  36. Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87: 4115

    Google Scholar 

  37. Ferraro G, Meroni PL, Tincani A, Sinico A, Barcellini W, Radice AGG, Froldi M, Borghi MO, Balestrieri G (1990) Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immuno 79: 47

    Google Scholar 

  38. Frampton G, Jayne DRW, Perry GJ, Lockwood CM, Cameron JS (1990) Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 82: 227

    Google Scholar 

  39. Gallicchio MC, Savige JA (1991) Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infection. Clin Exp Immunol 84: 232

    Google Scholar 

  40. Gaskin G, Ryan JJ, Rees AJ, Pusey CD (1991) ANCA specificity in microscopic polyarteritis, Churg-Strauss syndrome, and polyarteritis nodosa. Am J Kidney Dis 18: 207

    Google Scholar 

  41. Gaskin G, Savage COS, Ryan JJ, Jones S, Rees AJ, Lockwood CM, Pusey CD (1991) Anti-neutrophil cytoplasmic antibodies and disease activity during follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 6: 689

    Google Scholar 

  42. Gephardt G, Ahmad M, Tubbs R (1983) Pulmonary vasculitis (Wegener's granulomatosis). Immunohistochemical studies of T and B cell markers. Am J Med 74: 700

    Google Scholar 

  43. Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg CGM, von dem Borne AEGKR (1989) Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorphosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 84: 1577

    Google Scholar 

  44. Gordon M, Luqmani RA, Adu D, Greaves I, Richards N, Michael J, Emery P, Howie AJ, Bacon PA (1993) Relapses in patients with a systemic vasculitis. Q J Med 86: 779

    Google Scholar 

  45. Gower RG, Sams WM Jr, Thorne EG, Kohler PF, Claman HN (1977) Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol 69: 477

    Google Scholar 

  46. Gross WL (1989) Serum cytokine changes in systemic vasculitis. Immunology 68: 196

    Google Scholar 

  47. Hauser IA, Johnson DR, Madri JA (1993) Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion. J Immunol 151: 5172

    Google Scholar 

  48. Hay EM, Beaman M, Ralston AJ, Ackrill P, Bernstein RM, Holt PJL (1991) Wegener's granulomatosis occuring in siblings. Br J Rheumatol 30: 144

    Google Scholar 

  49. Hergesell O, Andrassy K, Nawroth P, Gabat S (1993) Endothelial dysfunction and activation of haemostasis (anticardiolipin antibodies, thrombin-antithrombin complexes (TAT), prothrombin fragments (F1+2), D-Dimers) as markers of disease activity in patients with systemic necrotizing vasculitis. Thromb Haemost 69: 953

    Google Scholar 

  50. Hughes CCW, Savage COS, Pober JS (1990) The endothelial cell as a regulator of T-cell function. Immunol Rev 117: 85

    Google Scholar 

  51. Jayne DRW, Jones SJ, Severn A, Shaunak S, Murphy J, Lockwood CM (1989) Severe pulmonary hemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasm antibodies of IgM class only. Clin Nephrol 32: 101

    Google Scholar 

  52. Jayne DRW, Davies MJ, Fox CJV, Black CM, Lockwood CM (1990) Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 337: 1137

    Google Scholar 

  53. Jayne DRW, Weetman AP, Lockwood CM (1991) IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 84: 476

    Google Scholar 

  54. Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL (1990) Wegener's autoantigen decoded. Nature 346: 520

    Google Scholar 

  55. Jennette JC, Wilkman AS, Falk RJ (1989) Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135: 921

    Google Scholar 

  56. Jennette JC, Hoidal JH, Falk RJ (1990) Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 78: 2263

    Google Scholar 

  57. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 37: 187

    CAS  PubMed  Google Scholar 

  58. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ (1987) New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxidase-halide system. J Clin Invest 79: 1379

    Google Scholar 

  59. Katz P, Alling DW, Haynes BF, Fauci AS (1979) Association of Wegener's granulomatosis with HLA-B8. Clin Immunol Immunopathol 14: 268

    Google Scholar 

  60. Kawasaki K, Yaoita E, Yamamoto T, Tamatani T, Miyasaka M, Kihara I (1993) Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 150: 1074

    Google Scholar 

  61. Kekow J, Szymkowiak CH, Gross WL (1992) Involvement of cytokines in granuloma formation within primary systemic vasculitis. In: Romagni S (ed) Cytokines: basic principles and clinical applications. Raven Press, New York, pp 341–348

    Google Scholar 

  62. Keogan MT, Esnault VLM, Green AJ, Lockwood CM, Brown DL (1992) Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 90: 228

    Google Scholar 

  63. Kirby JA, Lin Y, Browell DA (1993) Renal allograft rejection: examination of adhesion blockade by antilymphocyte antibody drugs. Nephrol Dial Transplant 8: 544

    Google Scholar 

  64. Koderisch J, Andrassy K, Rasmussen N, Hartmann M, Tilgen W (1990) “False-positive” anti-neutrophil cytoplasmic antibodies in HIV infection. Lancet II: 1227

    Google Scholar 

  65. Lee SS, Adu D, Thompson RA (1990) Anti-myeloperoxidase antibodies in systemic vasculitis. Clin Exp Immunol 79: 41

    Google Scholar 

  66. Lhotta K, Neumayer HP, Joannidis M, Geissler D, Konig P (1991) Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis. Clin Sci 81: 477

    Google Scholar 

  67. Mark EJ, Matsubara O, Tan-liu NS, Fienberg R (1988) The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis. Hum Pathol 19: 1065

    Google Scholar 

  68. Mathieson PW, Cobbold SP, Hale G, Clark MR, Oliveira DBG, Lockwood CM, Waldmann H (1990) Monoclonal antibody therapy in systemic vasculitis. N Engl J Med 323: 250

    Google Scholar 

  69. Mathieson PW, Qasim FJ, Esnault VLM, Oliveira DBG (1993) Animal models of systemic vasculitis. J Autoimmun 6: 251

    Google Scholar 

  70. Mayet WJ, Csernok E, Szymkowiak C, Gross WL, Meyer zum Büschenfelde KH (1993) Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 82: 1221

    Google Scholar 

  71. Mayet WJ, Meyer zum Büschenfelde KH (1993) Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 94: 440

    Google Scholar 

  72. Mulder AHL, Horst G, Limburg PC, Kallenberg CGM (1993) Activation of neutrophils by antineutrophil cytoplasmic antibodies (ANCA) is FcR dependent. Clin Exp Immunol 93 Suppl 1: 16

    Google Scholar 

  73. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA (1989) Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74: 1888

    Google Scholar 

  74. Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R (1993) In situ production of TNFα, IL-1β and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 43: 682

    Google Scholar 

  75. Novak RF, Christiansen RG, Sorensen ET (1982) The acute vasculitis of Wegener's granulomatosis in renal biopsies. Am J Clin Pathl 78: 367

    Google Scholar 

  76. Pall AA, Adu D, Richards NT, Michael J (1993) Pooled human immunoglobulin (PHIG) inhibits the binding of antiendothelial cell antibodies to endothelial cells. Nephrol Dial Transplant 8: 1428

    Google Scholar 

  77. Pall AA, Garner CM, Richards GM, Howie AJ, Adu D, Taylor CM, Richards NT, Michael J (1993) Expression of E-selectin in the human kidney. Nephrol Dial Transplant 8: 1429

    Google Scholar 

  78. Pall AA, Adu D, Drayson M, Taylor CM, Richards NT, Michael J (1994) Circulating soluble adhesion molecules in systemic vasculitis. Nephrol Dial Transplant (in press)

  79. Pall AA, Howie AJ, Adu D, Richards GM, Inward CD, Milford DV, Richards NT, Michael J, Taylor CM (1994) Glomerular VCAM-1 expression in renal vasculitis. Nephrol Dial Transplant (in press)

  80. Pall AA, Varagunam M, Adu D, Smith N, Richards NT, Taylor CM, Michael J (1994) Anti-idiotypic-activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin. Clin Exp Immunol 95: 257

    Google Scholar 

  81. Petterson E, Heigl Z (1992) Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study. Clin Nephrol 37: 219

    Google Scholar 

  82. Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK (1984) Relapses in Wegener's granulomatosis: the role of infection. Br Med J 281: 836

    Google Scholar 

  83. Pober JS, Cotran RS (1990) Cytokines and endothelial cell biology. Physiol Rev 70: 427

    Google Scholar 

  84. Rasmussen N, Petersen J (1993) Cellular immune responses and pathogenesis in c-ANCA positive vasculitides. J Autoimmun 6: 227

    Google Scholar 

  85. Rasmussen N, Petersen J, Ralfkiaer E, Avnstrom S, Wiik A (1988) Spontaneous and induced immunoglobulin synthesis and anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: relation to leukocyte subpopulations in blood and active lesions. Rheumatol Int 8: 153

    Google Scholar 

  86. Reinisch CL, Moyer CF (1991) Animal models of vasculitis. In: Churg A, Churg J (eds) Systemic vasculitides. Igaku-Shoin, New York, pp 31–40

    Google Scholar 

  87. Rossi F, Jayne DRW, Lockwood CM, Kazatchkine MD (1991) Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission serum of patients with systemic vasculitis. Clin Exp Immunol 83: 298

    Google Scholar 

  88. Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985) Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 56: 467

    Google Scholar 

  89. Savage COS, Winearls CG, Jones S, Marshall PD, Lockwood CM (1987) Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet I: 1389

    Google Scholar 

  90. Savage COS, Pottinger B, Gaskin G, Lockwood CM, Pusey CD, Pearson J (1991) Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 85: 14

    Google Scholar 

  91. Savage COS, Pottinger BE, Gaskin G, Pusey CD, Pearson JD (1992) Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells. Am J Pathol 141: 335

    Google Scholar 

  92. Savage COS, Brooks C, Picard J, Harcourt G, Willcox N (1993) Processing and presentation of peptides by vascular endothelial cells to CD4+ T cell lines. Clin Exp Immunol 93 [Suppl 1]: 19

    Google Scholar 

  93. Savage COS, Gaskin G, Pusey CD, Pearson JD (1993) Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens. Exp Nephrol 1: 190

    Google Scholar 

  94. Savige JA, Gallicchio MC, Stockman A, Cummingham TJ, Rowlay MJ (1991) Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol 86: 92

    Google Scholar 

  95. Saxon A, Shanahan F, Landers C (1990) A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86: 202

    Google Scholar 

  96. Scott DGI (1993) Classification of vasculitis. In: Maddison PJ, Isenberg DA, Woo P, Glass DN (eds) Oxford textbook of rheumatology, vol 2. Oxford Medical Publications, Oxford, pp 842–846

    Google Scholar 

  97. Seron D, Cameron JS, Haskard DO (1991) Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant 6: 917

    Google Scholar 

  98. Spencer SJW, Burns A, Gaskin G, Pusey CD, Rees AJ (1992) HLA class II specificities and the development and duration of small vessel vasculitis. Kidney Int 41: 1059

    Google Scholar 

  99. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301

    Article  CAS  PubMed  Google Scholar 

  100. Stegeman CA, Cohen Tervaert JW, Huitema MG, Kallenberg CGM (1993) Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 91: 415

    Google Scholar 

  101. van de Wiel BA, Dolman KM, van der Meer-Gerritsen CH, Hack CE, von dem Borne AEGK, Goldschmeding R (1992) Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity. Clin Exp Immunol 90: 409

    Google Scholar 

  102. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet I: 425

    Google Scholar 

  103. van der Woude FJ, van Es LA, Daha MRI (1990) The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms. Neth J Med 36: 169

    Google Scholar 

  104. Varagunam M, Adu D, Taylor CM, Michael J, Richards N, Neuberger J, Thompson RA (1992) Endothelium myeloperoxidase-antimyeloperoxidase interaction in vasculitis. Nephrol Dial Transplant 7: 1077

    Google Scholar 

  105. Varagunam M, Nwosu Z, Adu D, Garner C, Taylor CM, Michael J, Thompson RA (1992) Little evidence for anti-endothelial cell antibodies in microscopic polyarteritis and Wegener's granulomatosis. Nephrol Dial Transplant 8: 113

    Google Scholar 

  106. Weiss MA, Crissman JD (1984) Renal biopsy findings in Wegener's granulomatosis: segmental necrotizing glomerulonephritis with glomerular thrombosis. Hum Pathol 15: 943

    Google Scholar 

  107. Zimmerman GA, Prescott SM, McIntyre TM (1992) Endothelial cell interactions with granulocytes: tethering and signalling molecules. Immunol Today 13: 93

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renal Immunobiology Group, CCRIS, Medical School, and Renal Unit, Department of Medicine, University of Birmingham, B15 2TT, Edgbaston, Birmingham, UK

    Abeed A. Pall & Caroline O. S. Savage

Authors
  1. Abeed A. Pall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline O. S. Savage
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pall, A.A., Savage, C.O.S. Mechanisms of endothelial cell injury in vasculitis. Springer Semin Immunopathol 16, 23–37 (1994). https://doi.org/10.1007/BF00196711

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00196711

Keywords

Search

Navigation